Voices from the Frontline: Adjuvant CDK4/6 Therapy in HR+ HER2- Breast Cancer
Thu, Apr 16
|Capital Grille
Master High-Risk Early Breast Cancer Care at This Exclusive Workshop!
Time & Location
Apr 16, 2026, 5:30 PM – 7:00 PM
Capital Grille, 900 Boylston St, Boston, MA 02115, USA
Guests
About The Event
Voices from the Frontline: Adjuvant CDK4/6 Therapy in HR+ HER2- Breast Cancer
Presented by: Jamie L. Carroll, APRN, CNP, MSN, Assistant Professor of Medical Oncology/Mayo Clinic, Rochester, MN
Adjuvant CDK4/6 inhibitors reduce recurrence risk in high-risk HR+, HER2- early breast cancer—yet adherence and toxicity management remain critical challenges. This on-demand program empowers oncology nurses and NPs with practical strategies to translate evidence into patient-centered care.
Through case-based learning and expert insights, participants will strengthen skills in recurrence risk assessment, proactive monitoring and management of adverse events (including neutropenia, GI toxicities, and ILD/pneumonitis), dose adjustment principles, and nursing-led interventions that promote long-term adherence and persistence. Downloadable quick-reference tools reinforce real-world application.